Dermatology

This site is intended for healthcare professionals only

Login Register

MD Brand Connect
Vaccine Hub
MDTV
Fact Check
Health Dialogues

Medical News & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry
MDTV

This site is intended for healthcare professionals only

Login Register

LoginRegister

Home
Medical news & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry

Susmita Roy

Mpharm (Pharmacology)

Susmita Roy, B pharm, M pharm Pharmacology, graduated from Gurunanak Institute of Pharmaceutical Science and Technology with a bachelor's degree in Pharmacy. She is currently working as an assistant professor at Haldia Institute of Pharmacy in West Bengal. She has been part of Medical Dialogues since March 2021.

Home

Susmita Roy

Articles By : Susmita Roy

Exemption to SII pneumococcal vaccine from price control for 5 years: NPPA

Susmita Roy18 April 2022 5:49 PM IST

New Delhi: In a major relief to Serum Institute of India, the drug price regulator, the National Pharmaceutical Pricing Authority (NPPA), has...

NPPA panel rejects Cadila Healthcare retail price fixation application for Tacrolimus PR capsules

Susmita Roy17 April 2022 12:00 PM IST

New Delhi: Citing that the Central Drugs Standard Control Organisation(CDSCO) has not given approval to Cadila Healthcare to import and manufacture...

Sun Pharma gets CDSCO committee approval for manufacturing Ranibizumab

Susmita Roy16 April 2022 3:22 PM IST

New Delhi: In a significant development, the Subject Expert Committee (SEC) functional under the Central Drugs Standard Control Organization (CDSCO)...

NPPA fixes ceiling price of two coronary stents

Susmita Roy3 April 2022 12:39 PM IST

New Delhi: After considering the Wholesale Price Index (WPI) at 10.76607% for the year 2021 over 2020, the National Pharmaceutical Pricing Authority,...

Macleod Pharma gets CDSCO panel conditional nod to study FDC Sitagliptin, Metformin, Glimepiride

Susmita Roy28 March 2022 7:02 PM IST

New Delhi: Pharmaceutical major, Macleods Pharmaceuticals has got the go-head from the Subject Expert Committee (SEC) of the Central Drug Standard...

Drug safety alert: IPC flags adverse reactions linked to Cephalosporin

Susmita Roy24 March 2022 7:39 PM IST

New Delhi: The Indian Pharmacopoeia Commission (IPC), through its recently issued drug safety alert for the month of March, has revealed that...

39 drug samples including Glenmark Telma H fail to clear CDSCO test, 1 declared misbranded

Susmita Roy17 March 2022 3:21 PM IST

New Delhi: In its latest drug safety alert, the apex drug regulatory body, the Central Drugs Standard Control Organization (CDSCO), has flagged 39...

Roche India Atezolizumab marketing approval to be revoked for two indications: CDSCO panel

Susmita Roy10 March 2022 6:50 PM IST

New Delhi: In a major setback to Roche Products (India), the Subject Expert Committee (SEC) of the Central Drugs Standard Control Organisation (CDSCO)...

IPC flags adverse reaction linked to antihypertensive drug Losartan

Susmita Roy3 March 2022 6:25 PM IST

New Delhi: The Indian Pharmacopoeia Commission (IPC), through its recently issued drug safety alert for the month of February, has revealed that...

Cipla gets CDSCO panel okay to manufacture, market Metformin, Sitagliptin FDC

Susmita Roy28 Feb 2022 1:19 PM IST

New Delhi: Pharmaceutical major, Cipla has got a go-ahead from the Subject Expert Committee (SEC) of the Central Drugs Standard Control Organization...

NPPA fixes retail price of 19 formulations, Details

Susmita Roy25 Feb 2022 3:23 PM IST

New Delhi: Through a recent notice, the National Pharmaceutical Pricing Authority (NPPA), Ministry of Chemicals and Fertilizers, Government of India,...

Intas pharma gets CDSCO panel nod to manufacture, market schizophrenia drug Clozapine

Susmita Roy21 Feb 2022 5:00 PM IST

New Delhi: Pharmaceutical major Intas Pharmaceuticals has got a green signal from the Subject Expert Committee (SEC) functional under the Central...

Powered By: Hocalwire

X

We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok